ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancrea... (elp patients diagnosed with this disease...)

ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer

Date:11/24/2008

elp patients diagnosed with this disease.

About Pancreatic Cancer

The pancreas is a gland deep in the abdomen, behind the stomach, that is part of the digestive and endocrine systems. The pancreas makes juices that help with digestion (enzymes) as well as important hormones such as insulin that control the level of sugar in the bloodstream. Pancreatic cancer is difficult to diagnose early, as the symptoms are often minor or non-existent until the tumor has extended outside the pancreas. Once outside the pancreas, the tumor invades a number of adjacent organs and is usually not amenable to surgical resection. There are no reliable early diagnostic tests for pancreatic cancer.

Scientific research is in the basic stages. Advancing pancreatic cancer research into the 21st century is dependent upon the increase of basic science research. Pancreatic cancer risk factors need to be identified and verified before research about prevention methods can begin. Recent research studies indicate that approximately 10 percent of pancreatic cancer cases are familial and another 30 percent are thought to result from cigarette smoking. Some other risk factors scientists are currently studying include: diabetes, chronic and hereditary pancreatitis (inflammation of the pancreas), obesity, physical activity, and diet.

"Screening for pancreatic cancer in relatives of affected people is not often done in the United States," said Pochapin. "However, families with many cases of pancreatic cancer or close relatives of people who developed pancreatic cancer at an early age should seek the advice of a specialist such as a gastroenterologist or oncologist, as there are specific genetic syndromes that may increase susceptibility for pancreatic cancer."

Symptoms and Detection

Since the pancreas is near the drainage tubes for bile and digestive enzymes, a mass in the pancreas can b
'/>"/>

SOURCE American Society for Gastrointestinal Endoscopy
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Tapestry Initiates Phase 2 Trial of TPI 287 for the Treatment of Advanced Pancreatic Cancer
2. EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer
3. Mayo Clinic Study Finds Further Association Between Diabetes and Pancreatic Cancer
4. Raven Announces Initiation of a RAV12 Phase 2 Clinical Trial in Metastatic Pancreatic Cancer
5. Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging
6. Senescos Preclinical Pancreatic Islet Data to be Presented at Upcoming Conferences
7. Senesco Expands on Recently Announced Preclinical Pancreatic Islet Data
8. Repligen Receives FDA Fast Track Designation for RG1068 for Pancreatic Imaging
9. Interim Analysis of Phase I/II Study of Rexin-G Confirms Efficacy With No Dose Limiting Toxicity in Metastatic Pancreatic Cancer
10. Patients with Pancreatic Cancer Can Benefit From Avastin(R) Plus Tarceva(R)
11. Anti-TGF-Beta Antisense AP 12009 Shows Very Good Safety and Tolerability in Systemic Treatment of Pancreatic Carcinoma, Malignant Melanoma and Colorectal Carcinoma

Post Your Comments:

(Date:12/15/2009)... REDWOOD CITY, Calif., Dec. 15 Genomic Health, ... five new studies on its Onco type DX® ... currently use to predict the likelihood of chemotherapy benefit ... These data were presented at the 32nd Annual CTRC-AACR ... 13, 2009, in San Antonio, TX. ,, "The breadth ...

(Date:12/15/2009)... Dec. 15 Arlington Medical Resources (AMR) ... aureus (MRSA) is the most concerning pathogen ... to their treatment of skin and skin structure ... the top factors that influences European physician drug ... Other key factors that drive prescribing include an ...

(Date:12/15/2009)... 15 Amylin Pharmaceuticals, Inc. ... (NYSE: LLY ) and Alkermes, Inc. ... from a head-to-head study comparing exenatide once weekly, ... taken twice daily, in patients with type 2 ... exenatide once weekly experienced a statistically superior reduction ...

Breaking Medicine Technology:Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 2 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 3 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 4 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 5 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 6 Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations 7 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 2 A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 2 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 3 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 4 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 5 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 6 Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study 7 U S Health Costs Will Continue to Cause Financial Pain 56659 1 Nabors Industries Ltd Third Quarter 2009 Earnings Conference Call Invitation 56654 1 Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference 13948 1 Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference 13948 2

[0] Genomic Health Announces New Data Reinforcing Clinical Utility of Oncotype DX(R) in Multiple Breast Cancer Populations [0] A Drug's Activity Against MRSA is Among the Top Factors That Influences European Physician Antibiotic Selection for Treating Skin and Skin Structure Infections [0] Exenatide Once Weekly Provided Superior Glucose Control Compared to BYETTA(R) in DURATION-5 Study

... Role in the Pathobiology, of Severe Asthma, Identify Potential New Biomarker for ... ... -, GAITHERSBURG, Md., Nov. 14 MedImmune, Inc. today,announced the ... molecule may play an,important role in determining the mechanisms of severe asthma. ...

... The American Legion,welcomes the findings of an Institute ... be released on Nov 14., "In view of ... health,of military personnel who have served in Iraq and ... timely and important," said Marty,Conatser, national commander of the ...

Other Medicine Technology:The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 2 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 3 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 4 The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma 5 American Legion Anticipates Institute of Medicine Report on Gulf War Veterans 2

The New England Journal of Medicine Publishes First Clinical Results for MedImmune's Chitinase-like Protein YKL-40 in Patients With Asthma American Legion Anticipates Institute of Medicine Report on Gulf War Veterans

(Date:12/15/2009)... -- Reportlinker.com announces that a new ... its catalogue: ,, The Future ... Forecasts to 2015, Competitive Benchmarking, Product ... http://www.reportlinker.com/p0168098/The-Future-of-Cardiovascular-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ,, Summary ... its latest research "The Future of ...

(Date:12/15/2009)... -- Aon Consulting, the global human capital ... AON ), today announced Lisa Zeitel ... president with the Health & Benefits Practice ... ,, (Logo: http://www.newscom.com/cgi-bin/prnh/20041215/CGW049LOGO ) ... work under the direction of Aon Consulting,s ...

(Date:12/15/2009)... shows a direct correlation between effective workplace health ... culture of health improvement can result in lower ... white paper from The Vitality Group, a provider ... ideal setting for the delivery of health and ... culture of health is a critical component in ...

(Date:12/15/2009)... CLARA, Calif., Dec. 15 Today, ... into Santa Clara County for the first ... Effective immediately, Coastal Healthcare Administrators will be ... by the Physicians Foundation for Medical Care. ... healthcare philosophy, Coastal maintains close working relationships ...

(Date:12/15/2009)... acid synthesis in brain cancer cells may offer a ... glioblastomas that are driven by amplified signaling of the ... study by researchers at UCLA,s Jonsson Comprehensive Cancer Center. ... the formation of new membranes. The fatty acids also ... and may be important for regulating cell signaling, said ...

[0] Reportlinker Adds The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] Aon Consulting Adds Senior Vice President to National Pharmacy Practice [0] Optimizing Corporate Culture is Critical to the Success of Wellness Programs [0] Coastal Healthcare Administrators Expands Provider Network to Santa Clara County [0] Targeting brain cancer cell metabolism may provide new treatment

... A new study finds that even a little extra income can ... ,"The surprise was at the upper end," said Meredith ... Aug. 17 issue of the New England Journal of Medicine. "We ... and the very rich. To find that the middle class was ...

... of Neurology projects the total cost of ischemic stroke from ... stroke victims playing a major role. ,The study, based ... at the costs of ischemic strokes, which account for the ... ambulances, hospital stays, medications, nursing home care, doctor’s visits and ...

... Shehnai maestro Bismillah Khan was hospitalised here Thursday due to ... 92, had fallen ill about a week ago and was ... ,However, he became very weak prompting the attending ... Varanasi Thursday morning. ,"Bismillah Khan Saheb had been ...

... in a government hospital in Madhya Pradesh allegedly died because his ... tie the umbilical cord.// ,Ram Milan, the father of ... wife to the government hospital in Satna for a safe delivery. ... ,"The nurse on duty demanded Rs.50 for tying the umbilical cord. ...

... agreement between Hewlett Packard and the government in Northern ... prescriptions towards the implementation// of an e-prescriptions service. ... Public Safety has announced that community pharmacies across Northern ... transfer prescriptions over the next two years. ...

... fell ill, five of them seriously, after eating stale food ... many as 44 children of Pratapura Primary School, 60 km ... ,The children complained of stomach ache and ... a day earlier. ,They were taken to ...

Other Medicine News:Health News:The higher the income the lower the disability rates! 2 Health News:Stroke Care Cost To Touch $2.2 trillion by 2050 2

The higher the income the lower the disability rates!Stroke Care Cost To Touch $2.2 trillion by 2050 Shehnai Maestro Bismillah Khan Hospitalised Bribery has Claimed the Life of a Newborn in Madhya Pradesh Paper Prescriptions Give Way to e-Prescriptions in Northern Ireland Students Fell Ill After Eating Stale Food on I-Day

Proven and Efficient Stand-Alone Device. Offers a choice between alternate breath and every breath delivery. This model provides every breath delivery....

Lightweight Pneumatic Conserver., ,NOTE: All models passed the ASTM PS 127-00 regulator ignition safety test....

... All-In-One Conserver., ,Offers an average 5:1 increase ... ,Allows the use of a standard cannula. , ... lightweight cylinders offers ambulatory oxygen patients a superior ... by a 2-year warranty. , ...

Redesigning the World's Oxygen Therapy One Device at a Time. , ,Everything you like about our OXYMATIC 400 Series conservers, only better!...

Medicine Products:

SEQUOIA OXYMATIC® 311 Electronic Oxygen Conserver 512 Lightweight Pneumatic Conserver OXYMATIC® 411A Electronic Oxygen Conserver LOTUS™ Electronic Oxygen Conserver (with alarm)

ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancrea...(elp patients diagnosed with this disease...),Health